Lorazepam kinetics in the elderly
The DOI matches its Crossref record.
Abstract
Lorazepam is a 3‐hydroxy‐1,4‐benzodiazepine derivative biotransformed by glucuronide conjugation, followed by urinary excretion of the glucuronide metabolite. The kinetic properties of single 1.5‐ to 3.0‐mg doses of intravenous lorazepam were assessed in 15 healthy elderly subjects, 60 to 84 yr of age, and in 15 healthy young subjects, 19 to 38 yr of age. Volumes of distribution for lorazepam in the elderly group (mean, 0.99 1/kg), were slightly but significantly smaller than in the young group (1.11 1/kg), suggesting less extensive drug distribution in the elderly. Values of elimination half‐life (t½β) in the elderly (15.9 hr) did not differ significantly from those in the young group (14.1 hr), but total clearance in the elderly (0.77 ml/min/kg) was 22% less (p < 0.05) than in the young subjects (0.99 ml/min/kg). Age differences in lorazepam clearance were partly explained by more frequent cigarette smoking in the young subjects. Gender had no apparent relationship to kinetics. The rate and completeness of absorption of intramuscular (IM) and oral lorazepam was assessed in 10 of the elderly subjects. Deltoid 1M injection and oral administration of tablets in the fasting state led to rapid absorption of lorazepam into the systemic circulation. Peak plasma lorazepam concentrations were always reached within 2.5 hr, and values of absorption half‐life (t½α) did not exceed 45 min. Absorption of IM and oral lorazepam was 80% to 100% complete. Thus, the aging process is associated with small changes in the kinetics of lorazepam. IM and oral administration of lorazepam in elderly persons, as in the case of young individuals, leads to rapid and nearly complete absorption into the systemic circulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mangoni, A. A., & Jackson, S. H. D. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,874
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Clinical Pharmacokinetics of Oxazepam and Lorazepam
Greenblatt, D. J. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106020-00001 · Cited by 367
Self-citationDrug glucuronidation in humans
Miners, J. O., & Mackenzie, P. I. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90065-t · Cited by 361
Diazepam disposition determinants
Greenblatt, D. J., Allen, M. D., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.40 · Cited by 348
Self-citation
Metadata
- Authors
- Greenblatt, D. J., Allen, M. D., Locniskar, A., Harmatz, J. S., & Shader, R. I.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1979-07
- Volume
- 26
- Issue
- 1
- Pages
- 103-113
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2423092877
- Cited by
- 154
- References
- 0
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lorazepam kinetics in the elderly. https://app.cochat.ai/papers/10.1002/cpt1979261103
- The paper
- Greenblatt, D. J., Allen, M. D., Locniskar, A., Harmatz, J. S., & Shader, R. I. (1979). Lorazepam kinetics in the elderly. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt1979261103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.